Varex Imaging's Top 5 Customers Drive 40% of 2025 Revenue

Ticker: VREX · Form: 10-K · Filed: Nov 18, 2025 · CIK: 1681622

Sentiment: mixed

Topics: Medical Imaging, X-ray Components, OEM Supplier, Customer Concentration, Industrial Inspection, Healthcare Technology, Global Manufacturing

TL;DR

**Varex's heavy reliance on a few major OEM customers is a red flag; diversification is key for long-term stability.**

AI Summary

Varex Imaging Corporation (VREX) reported that its top five customers, including Canon Medical Systems Corporation, United Imaging Healthcare, General Electric Company, Siemens Healthineers AG, and Rapiscan Systems, Inc., collectively accounted for approximately 40% of total revenue in fiscal year 2025. Canon alone represented approximately 18% of total revenue in fiscal year 2025, consistent with 18% in 2024 and 17% in 2023. The company's ten largest customers contributed approximately 52% of revenue in fiscal year 2025. Varex operates two segments: Medical and Industrial, producing over 27,000 X-ray tubes and 20,000 X-ray detectors annually. The Medical segment benefits from a large installed base of over 160,000 X-ray tubes and 170,000 X-ray detectors, with replacement and service forming a significant revenue portion. The Industrial segment, which includes Linatron X-ray linear accelerators and cargo inspection systems, generally achieves higher gross profit margins due to favorable pricing dynamics and long-term service agreements. Varex employs approximately 2,400 full-time equivalent employees and invests in research and development with around 400 individuals focused on product development.

Why It Matters

Varex's significant customer concentration, with its top five customers accounting for 40% of 2025 revenue and Canon alone representing 18%, poses a notable risk for investors. While long-term OEM relationships provide stability, any loss or reduction in business from these key players could severely impact VREX's financial performance and market share. The company's strong position as a leading independent X-ray imaging component supplier, with a vast installed base and continuous R&D investment, helps mitigate some competitive pressures from in-house OEM manufacturing and rivals like Trixell S.A.S. and iRay Technology. This competitive landscape means Varex must continually innovate and maintain cost-effectiveness to retain its critical OEM partnerships and ensure sustained growth in both medical and industrial imaging markets.

Risk Assessment

Risk Level: medium — Varex faces a medium risk level primarily due to significant customer concentration. Its top five customers accounted for approximately 40% of total revenue in fiscal year 2025, with Canon Medical Systems Corporation alone representing 18%. This reliance on a limited number of OEM customers makes Varex vulnerable to a reduction in or loss of business from any of these key accounts, as explicitly stated in the forward-looking statements.

Analyst Insight

Investors should monitor Varex's customer diversification efforts and new product adoption, particularly in the growing non-destructive testing and China healthcare markets. Evaluate the company's ability to maintain its competitive edge through R&D investments and cost-effective solutions to mitigate risks associated with its concentrated customer base.

Financial Highlights

debt To Equity
N/A
revenue
N/A
operating Margin
N/A
total Assets
N/A
total Debt
N/A
net Income
N/A
eps
N/A
gross Margin
N/A
cash Position
N/A
revenue Growth
N/A

Revenue Breakdown

SegmentRevenueGrowth
MedicalN/AN/A
IndustrialN/AN/A

Key Numbers

Key Players & Entities

FAQ

What are Varex Imaging Corporation's primary business segments?

Varex Imaging Corporation operates in two primary business segments: Medical and Industrial. The Medical segment focuses on X-ray imaging components for diagnostic imaging, while the Industrial segment provides X-ray imaging products for security inspection and non-destructive testing applications.

Who are Varex Imaging's largest customers and what is their revenue contribution?

Varex Imaging's top five customers, including Canon Medical Systems Corporation, United Imaging Healthcare, General Electric Company, Siemens Healthineers AG, and Rapiscan Systems, Inc., collectively accounted for approximately 40% of total revenue in fiscal year 2025. Canon Medical Systems Corporation alone contributed approximately 18% of total revenue in fiscal year 2025.

What is the replacement cycle for Varex Imaging's CT X-ray tubes?

CT X-ray tubes manufactured by Varex Imaging generally need to be replaced every 2 to 6 years. In China, due to high utilization of imaging equipment, the replacement cycle for CT X-ray tubes can be as frequent as every 10 to 20 months.

How many employees does Varex Imaging have and how many are in R&D?

Varex Imaging Corporation has approximately 2,400 full-time equivalent employees globally. Approximately 400 of these individuals are employed in product development-related activities, demonstrating a significant investment in research and development.

What are the key competitive advantages for Varex Imaging in the Medical segment?

In the Medical segment, Varex Imaging's competitive advantages include innovative technology, superior product performance and quality, better product availability, and lower product prices compared to in-house OEM manufacturing. Their products are often customized and tightly integrated, making it costly and complex for customers to switch providers.

What are the main risks associated with Varex Imaging's customer base?

A main risk is the significant customer concentration, with the top five customers accounting for 40% of 2025 revenue. The loss or reduction of business from one or more of these limited OEM customers could significantly impact Varex Imaging's financial results, as highlighted in the forward-looking statements.

Where does Varex Imaging manufacture its products?

Varex Imaging manufactures its products at facilities located in the United States, the United Kingdom, the Netherlands, Germany, Finland, the Philippines, China, and India. These facilities are certified by the International Standards Organization (ISO) under ISO 9001 or ISO 13485.

What is Varex Imaging's strategy for growth in China?

Varex Imaging's long-term objective in China is to become the partner of choice for both new systems and replacement components as CT systems become more widely adopted. They are actively developing CT X-ray tubes and related subsystems for Chinese OEMs.

How does Varex Imaging's Industrial segment compare in profitability to its Medical segment?

Varex Imaging's Industrial segment generally achieves higher gross profit for its products relative to its Medical business. This is attributed to more favorable pricing dynamics and the benefits derived from research and development investment and manufacturing economies of scale from the Medical side.

What types of products does Varex Imaging offer for security applications?

For security applications, Varex Imaging offers Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, flat panel and photon counting detectors, and computed radiography scanners. These are used for cargo screening at ports and borders, and baggage screening at airports.

Risk Factors

Industry Context

Varex operates in the X-ray imaging component market, serving both medical and industrial sectors. The medical imaging component market is characterized by a high degree of OEM integration and a need for continuous innovation to support advanced diagnostic modalities like CT and mammography. The industrial segment, including security and quality inspection, benefits from specialized applications and long-term service agreements. Competition likely involves other component suppliers and potentially in-house development by large OEMs.

Regulatory Implications

Varex's products are subject to stringent regulatory requirements in the medical, security, and industrial sectors globally. Compliance with standards set by bodies like the FDA (in the US) and equivalent international organizations is essential for market access and product approval. Any changes in these regulations or failure to comply could impact product development, manufacturing, and sales.

What Investors Should Do

  1. Monitor customer concentration risk
  2. Assess R&D effectiveness and new product pipeline
  3. Evaluate segment performance and margin drivers

Glossary

OEM
Original Equipment Manufacturer. A company that manufactures products based on designs supplied by another company. (Varex primarily sells its X-ray components to OEMs who integrate them into their larger imaging systems, making OEM relationships crucial for Varex's business.)
Computed Tomography (CT)
A medical imaging procedure that uses X-ray equipment to create detailed cross-sectional images of the body. (Varex's Medical segment components are used in CT scanners, a significant application area for their products.)
Linatron X-ray linear accelerators
A type of particle accelerator used in industrial applications for tasks like cargo inspection and industrial quality control. (These are key products within Varex's Industrial segment, contributing to higher gross profit margins.)
Photon Counting Detectors
An advanced type of X-ray detector that counts individual X-ray photons, offering potentially higher image quality and lower radiation dose compared to traditional detectors. (Varex designs and manufactures these detectors, indicating investment in cutting-edge medical imaging technology.)

Year-Over-Year Comparison

The provided text does not contain comparative data from the previous fiscal year. Therefore, a comparison of key metrics such as revenue growth, margin changes, or new risks cannot be performed based on this excerpt.

Filing Stats: 4,326 words · 17 min read · ~14 pages · Grade level 15.7 · Accepted 2025-11-18 16:10:57

Filing Documents

Business

Business 3 Item 1A.

Risk Factors

Risk Factors 13 Item 1B. Unresolved Staff Comments 27 Item 1C. Cybersecurity 27 Item 2.

Properties

Properties 28 Item 3.

Legal Proceedings

Legal Proceedings 29 Item 4. Mine Safety Disclosures 29 Part II. 30 Item 5. Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 30 Item 6. [Reserved] 30 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 30 Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 39 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 40 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures 40 Item 9A.

Controls and Procedures

Controls and Procedures 40 Item 9B. Other Information 43 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 43 Part III. 44 Item 10. Directors, Executive Officers and Corporate Governance 44 Item 11.

Executive Compensation

Executive Compensation 44 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 45 Item 13. Certain Relationships and Related Transactions, and Director Independence 45 Item 14. Principal Accountant Fees and Services 45 Part IV. 46 Item 15. Exhibits and Financial Statement Schedules 46 Item 16. Form 10-K Summary 48

Signatures

Signatures 49 1 Table of Contents

Forward-Looking Statements

Forward-Looking Statements This Annual Report on Form 10-K (this "Annual Report"), including the section entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations" ("MD&A") contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, which provides a "safe harbor" for statements about future events, and financial performance that are based on the beliefs of, estimates made by, and information currently available to the management of Varex Imaging Corporation ("we," "our," "us," the "Company," or "Varex,"). Actual results and the outcome or timing of certain events described in these forward-looking statements are subject to risk and uncertainties and may differ significantly from those described. Important factors that could cause our actual results and financial condition to differ significantly from those projections or expectations include, among other things, the following: changes in import/export regulatory regimes, tariffs, trade wars, and national policies, including exemptions thereto; reduction in or loss of business of one or more of our limited original equipment manufacturing ("OEM") customers; global, regional, and country-specific economic instability, shifting political environments, changing tax treatment, tariffs, trade wars, and other risks associated with international manufacturing, operations, and sales; loss of business to, and an inability to effectively compete with, competitors; pricing pressures and other factors that could result in margin erosion and loss of customers; failure to meet customers' needs and demands; supply chain disruptions resulting in delayed product delivery, and increased costs as a result of reliance on a limited number of suppliers for certain key components; disruption of critical information systems or material breaches in the security of our systems or systems of third parties upon which we rely; inability to main

Business

Item 1. Business Overview Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components including X-ray tubes, flat panel and photon counting detectors and accessories, linear accelerators, image software processing solutions, and stand-alone X-ray based systems in select application areas. Our components are used in medical diagnostic imaging, security inspection systems, and industrial quality inspection systems, as well as for analysis and measurement applications in industrial manufacturing applications. Global OEMs incorporate our X-ray imaging components into their systems to detect, diagnose, protect, irradiate, and inspect. Varex has approximately 2,400 full-time equivalent employees, located at engineering, manufacturing, and service center sites in North America, Europe, and Asia. Our products are sold in three geographic regions: the Americas, EMEA, and APAC. The Americas includes North America (primarily the United States) and Latin America. EMEA includes Europe, the Middle East, India, and Africa. APAC includes Asia (other than India) and Australia. Revenues by region are based on the known final destination of products sold. Our success depends, among other things, on our ability to anticipate and respond to changes in our business, the direction of technological innovation, and the demand from our customers. We continually invest in research and development and employ approximately 400 individuals in product development related activities. Our focus on innovation and product performance along with strong and long-term customer relationships allows us to collaborate with our customers to deliver industry-leading X-ray imaging products. We continue to work to improve the life and quality of our imaging components and leverage our scale as one of the largest independent X-ray imaging component suppliers to provide cost-effective solutions for our customers. Operating Segments and Products We have two repo

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing